Evolution of Epidermal Growth Factor Receptor (EGFR) Gene Mutations in EGFR-TKIs Treated Chinese NSCLC

被引：0
|
作者：
Yu, X. [1 ,2 ]
Liu, X. [3 ]
Huang, M. [3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Shenzhen, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Peoples R China
[3] 3D Med Inc, Dept Med, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
real world data; EGFR; longitudinal molecular testing;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P76.45
引用
收藏
页码：S606 / S607
页数：2
相关论文
共 50 条
  • [1] Molecular predictors for epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): role of egfr gene amplification
    Cappuzzo, Federico
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S156 - S157
  • [2] Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs)
    Zhu, Lulin
    Yang, Xinxin
    Wu, Shanshan
    Dong, Rong
    Yan, Youyou
    Lin, Nengming
    Zhang, Bo
    Tan, Biqin
    DRUG METABOLISM REVIEWS, 2024, 56 (03) : 302 - 317
  • [3] Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Zheng, Aimin
    Huang, Guanghui
    Li, Wenhong
    Wang, Jiao
    Han, Xiaoying
    Meng, Min
    Ni, Yang
    ONCOTARGET, 2017, 8 (34) : 56714 - 56725
  • [4] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    S. Chen
    J. Zhao
    L. Cui
    Y. Liu
    Clinical and Translational Oncology, 2017, 19 : 332 - 340
  • [5] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    Chen, S.
    Zhao, J.
    Cui, L.
    Liu, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (03): : 332 - 340
  • [6] Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
    Zhang, Chengjuan
    Wei, Bing
    Li, Peng
    Yang, Ke
    Wang, Zhizhong
    Ma, Jie
    Guo, Yongjun
    PLOS ONE, 2017, 12 (03):
  • [7] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [8] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
    Xiong, Liwen
    Cui, Shaohua
    Ding, Jingyan
    Sun, Yun
    Zhang, Longfu
    Zhao, Yizhuo
    Gu, Aiqin
    Chu, Tianqing
    Wang, Huimin
    Zhong, Hua
    Ye, Xin
    Gu, Yi
    Zhang, Xin
    Hu, Min
    Jiang, Liyan
    ONCOTARGET, 2017, 8 (38) : 63846 - 63856
  • [9] Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy
    Aydiner, Adnan
    Sari, Murat
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
    Wen, Miaomiao
    Xia, Jinghua
    Sun, Ying
    Wang, Xuejiao
    Fu, Xianghui
    Zhang, Yanning
    Zhang, Zhipei
    Zhou, Yongan
    Li, Xiaofei
    BIOLOGICS-TARGETS & THERAPY, 2018, 12 : 183 - 190
12345